Infliximab therapy in pediatric Crohn’s disease: a review

Anti-tumor necrosis factor alpha (TNF-α) therapy has re-defined our treatment paradigms in managing patients with Crohn’s disease (CD) and ulcerative colitis. Although the ACCENT studies showed proven efficacy in the induction and maintenance of disease remission in adult patients with moderate to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Parashette, Kalyan Ray, Makam, Raghavendra Charan, Cuffari, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108658/
https://www.ncbi.nlm.nih.gov/pubmed/21694847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108658/
https://www.ncbi.nlm.nih.gov/pubmed/21694847

Ejemplares similares